The test detects the MET protein that is over-expressed in some patients with non-squamous non-small cell lung cancer.

A new study published in Aging Cell demonstrates that artificial intelligence can be used not just to accelerate drug ...

FDA grants accelerated approval to AbbVie's Emrelis for c-Met overexpressing NSCLC; siRNA partnership with ADARx includes ...

Mount Sinai researchers have found that a brain region that is implicated extensively in value-based decision-making and ...

Telix Pharmaceuticals excels in radiopharmaceuticals, with strong revenue growth driven by imaging products like Illuccix.

Growth stocks, particularly those in the biotech sector, can be lucrative long-term investments. The biotech sector often ...

ADRX-0706, a Nectin-4-targeted antibody-drug conjugate, has earned FDA fast track designation in advanced cervical cancer.

The FDA has issued a Complete Response Letter to Telix Pharmaceuticals regarding the NDA for TLX101-CDx for the imaging of gliomas.

Revenue: Total revenue, consisting primarily of revenue from collaboration agreements, was $15 million for the first quarter ...

NTS071 is an oral small molecule allosteric reactivator targeting p53 Y220C with a novel scaffold. It selectively binds to ...

SHANGHAI, April 30, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, presented 6 study results of innovative drugs and platforms in ...